Quick Answer
Enveric Biosciences, Inc. reported Gross Profit of $8.15 million for fiscal year 2019.
Enveric Biosciences, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2019 | $8.15M | -9.3% |
| 2018 | $8.98M | -12.3% |
| 2017 | $10.24M | +47.8% |
| 2016 | $6.93M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $1.89M | -0.6% | +3.8% |
| June 30, 2020 | $1.82M | -23.7% | -3.4% |
| March 31, 2020 | $1.88M | -12.1% | -0.9% |
| September 30, 2019 | $1.90M | -19.0% | -20.3% |
| June 30, 2019 | $2.38M | -0.3% | +11.3% |
| March 31, 2019 | $2.14M | -8.7% | -8.8% |
| September 30, 2018 | $2.35M | -8.5% | -1.8% |
| June 30, 2018 | $2.39M | +2.4% | +2.0% |
- Enveric Biosciences, Inc. showed a decrease of -9.3% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2019 period, Enveric Biosciences, Inc.’s gross profit has grown by 17.6% (from $6.93 million to $8.15 million).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 25, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: